Masuda Teruaki, Ueda Mitsuharu, Suenaga Genki, Misumi Yohei, Tasaki Masayoshi, Izaki Ayane, Yanagisawa Yukako, Inoue Yasuteru, Motokawa Hiroaki, Matsumoto Sayaka, Mizukami Mayumi, Arimura Aiko, Deguchi Takahisa, Nishio Yoshihiko, Yamashita Taro, Inomata Yukihiro, Obayashi Konen, Ando Yukio
From the Department of Neurology (T.M., M.U., G.S., Y.M., M.T., Y.I., H.M., S.M., M.M., T.Y., Y.A.) and Departments of Transplantation and Pediatric Surgery (Y.I.), Graduate School of Medical Sciences, and Department of Morphological and Physiological Sciences (M.T., A.I., Y.Y., K.O.), Graduate School of Health Sciences, Kumamoto University; and Department of Diabetes and Endocrine Medicine (A.A., T.D., Y.N.), Kagoshima University Graduate School of Medical and Dental Sciences, Japan.
Neurology. 2017 Jun 6;88(23):2192-2197. doi: 10.1212/WNL.0000000000004016. Epub 2017 May 10.
To elucidate early skin denervation in hereditary transthyretin (TTR) amyloidosis and iatrogenic TTR amyloidosis.
We investigated intraepidermal nerve fiber density (IENFD) and clinical findings in 32 patients with hereditary TTR amyloidosis, 11 asymptomatic mutation carriers, 6 patients with iatrogenic TTR amyloidosis, and 23 healthy volunteers.
IENFD values were reduced in patients with the V30M mutation (1.9 ± 2.1 per 1 mm), patients with non-V30M mutations (5.8 ± 3.2 per 1 mm), and patients with iatrogenic TTR amyloidosis (3.5 ± 1.8 per 1 mm) compared with healthy volunteers (11.8 ± 3.2 per 1 mm) ( < 0.01). Skin denervation also occurred, even in presymptomatic V30M mutation carriers (5.0 ± 2.2 per 1 mm). The IENFD was correlated with disease duration (ρ = -0.533, = 0.002) and various peripheral neuropathy parameters such as sensory impairment in the Kumamoto clinical score (ρ = -0.575, = 0.001), heat-pain detection threshold (ρ = -0.704, < 0.001), and sural sensory nerve action potential (ρ = 0.481, = 0.005). TTR amyloid deposits frequently occurred in connective tissues and vessels of the dermal reticular layer in patients with hereditary TTR amyloidosis and those with iatrogenic TTR amyloidosis.
Patients with hereditary TTR amyloidosis and those with iatrogenic TTR amyloidosis may show early skin denervation even in the presymptomatic stage. IENFD may thus be useful for early diagnosis and may serve as a biomarker in clinical trials for hereditary and iatrogenic TTR amyloidosis.
阐明遗传性转甲状腺素蛋白(TTR)淀粉样变性和医源性TTR淀粉样变性中的早期皮肤去神经支配情况。
我们调查了32例遗传性TTR淀粉样变性患者、11例无症状突变携带者、6例医源性TTR淀粉样变性患者和23名健康志愿者的表皮内神经纤维密度(IENFD)及临床发现。
与健康志愿者(11.8±3.2条/1mm)相比,V30M突变患者(1.9±2.1条/1mm)、非V30M突变患者(5.8±3.2条/1mm)和医源性TTR淀粉样变性患者(3.5±1.8条/1mm)的IENFD值降低(P<0.01)。即使在症状前V30M突变携带者中(5.0±2.2条/1mm)也出现了皮肤去神经支配。IENFD与疾病持续时间相关(ρ=-0.533,P=0.002),并与各种周围神经病变参数相关,如熊本临床评分中的感觉障碍(ρ=-0.575,P=0.001)、热痛检测阈值(ρ=-0.704,P<0.001)和腓肠感觉神经动作电位(ρ=0.481,P=0.005)。在遗传性TTR淀粉样变性患者和医源性TTR淀粉样变性患者中,TTR淀粉样沉积物经常出现在真皮网状层的结缔组织和血管中。
遗传性TTR淀粉样变性患者和医源性TTR淀粉样变性患者即使在症状前阶段也可能出现早期皮肤去神经支配。因此,IENFD可能有助于早期诊断,并可作为遗传性和医源性TTR淀粉样变性临床试验中的生物标志物。